Activator protein 2alpha inhibits tumorigenicity and represses vascular endothelial growth factor transcription in prostate cancer cells.
about
Activator protein 2alpha suppresses intestinal tumorigenesis in the Apc(min) mouseActivator protein 2alpha associates with adenomatous polyposis coli/beta-catenin and Inhibits beta-catenin/T-cell factor transcriptional activity in colorectal cancer cellsAP-2gamma induces p21 expression, arrests cell cycle, and inhibits the tumor growth of human carcinoma cellsProof of concept for microarray-based detection of DNA-binding oncogenes in cell extractsAurora-A interacts with AP-2α and down regulates its transcription activityRegulation of poly(ADP-ribose) polymerase-1 (PARP-1) gene expression through the post-translational modification of Sp1: a nuclear target protein of PARP-1Evolutionary conservation of zinc finger transcription factor binding sites in promoters of genes co-expressed with WT1 in prostate cancern-Butylidenephthalide induced apoptosis in the A549 human lung adenocarcinoma cell line by coupled down-regulation of AP-2alpha and telomerase activity.Identification of functional TFAP2A and SP1 binding sites in new TFAP2A-modulated genesReduced expression of transcription factor AP-2α is associated with gastric adenocarcinoma prognosisLeptin upregulates VEGF in breast cancer via canonic and non-canonical signalling pathways and NFkappaB/HIF-1alpha activationA miR-200b/200c/429-binding site polymorphism in the 3' untranslated region of the AP-2α gene is associated with cisplatin resistance.Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiationHIPSTR and thousands of lncRNAs are heterogeneously expressed in human embryos, primordial germ cells and stable cell linesTranscriptional regulation of ULBP1, a human ligand of the NKG2D receptor.Loss of AP-2alpha results in deregulation of E-cadherin and MMP-9 and an increase in tumorigenicity of colon cancer cells in vivo.Tumor-specific activation of human telomerase reverses transcriptase promoter activity by activating enhancer-binding protein-2beta in human lung cancer cells.Aberrant expressions of AP-2α splice variants in pancreatic cancerLeptin ameliorates ischemic necrosis of the femoral head in rats with obesity induced by a high-fat diet.Reversal of epigenetic silencing of AP-2alpha results in increased zinc uptake in DU-145 and LNCaP prostate cancer cells.Activating enhancer-binding protein-2α induces cyclooxygenase-2 expression and promotes nasopharyngeal carcinoma growth.Activator protein-2 in carcinogenesis with a special reference to breast cancer--a mini review.Mutations in the SOD2 promoter reveal a molecular basis for an activating protein 2-dependent dysregulation of manganese superoxide dismutase expression in cancer cellsA cell-autonomous role of Cited2 in controlling myocardial and coronary vascular development.Transcriptional control of melanoma metastasis: the importance of the tumor microenvironment.Driving transcriptional regulators in melanoma metastasis.Prostate cancer stroma: an important factor in cancer growth and progression.Identification of novel prostate cancer drivers using RegNetDriver: a framework for integration of genetic and epigenetic alterations with tissue-specific regulatory network.The nitrobenzoxadiazole derivative MC3181 blocks melanoma invasion and metastasisTranscription Factor AP2ε: A Potential Predictor of Chemoresistance in Patients With Gastric Cancer.Allele-specific transcriptional regulation of IRF4 in melanocytes is mediated by chromatin looping of the intronic rs12203592 enhancer to the IRF4 promoter.Androgen up-regulates vascular endothelial growth factor expression in prostate cancer cells via an Sp1 binding siteAP-2α-dependent regulation of Bcl-2/Bax expression affects apoptosis in the trophoblast.Regulation of vascular endothelial growth factor, VEGF, gene promoter by the tumor suppressor, WT1.Jak3- and JNK-dependent vascular endothelial growth factor expression in cutaneous T-cell lymphoma.Apoptosis induction by activator protein 2alpha involves transcriptional repression of Bcl-2.KAI1 promoter activity is dependent on p53, junB and AP2: evidence for a possible mechanism underlying loss of KAI1 expression in cancer cells.Association of the human astrocyte elevated gene-1 promoter variants with susceptibility to hepatocellular carcinoma.TFAP2E hypermethylation was associated with survival advantage in patients with colorectal cancer.Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors
P2860
Q24646807-6445FF8E-E770-4031-9283-DEC01A3B07DFQ24648448-DCE06D5F-747B-4711-90F8-D6E9D4DFB867Q24676129-CE04E25E-DA23-4F23-B8CE-C11A79474DA5Q24803007-22B3B716-1B9F-4E1B-A36C-F0370ED974F0Q28741932-C9C241CC-DB3F-48C1-ADDE-3010225C23AFQ33303916-ABA13919-81C7-432A-B052-D35FFEBAFE5FQ33352317-F6899CF8-27D7-4650-8BB4-9C07A7A8C844Q33554943-99A7995A-4B69-447B-BF63-0F210C50BF0AQ33595109-BF2EDED1-BC9A-441F-8BE1-E231609D3B2CQ34037832-A0A376FE-59EF-4E90-BAA2-BEF90CC0CD0BQ34085964-F4BB9653-8D85-4847-87B1-345D82E80C0DQ34110688-EF61E261-5354-4947-A49B-FBEB2D7799BAQ34405013-02588119-ABFF-4C8C-8267-0D4C77AE31E7Q34539755-3C8A77D3-8CC1-490D-A343-2327BCCBB132Q34556241-A74B6424-AA3A-4B5B-A26C-B790D38EF875Q34602271-9A54CC56-3993-424C-9A6A-43D5A4615948Q34650595-A05C4CC6-A85C-466B-A38C-DD18AB909EDDQ35049500-258BCE36-E53B-48D4-8905-9B80D8737CBCQ35206187-C33601C0-FE1B-44EF-8E64-80CCD48CE956Q35562908-A0C274B7-7B9D-4580-956C-6F48F60D040AQ35741600-7CF90661-25F9-4C59-BF9A-8B69B7512615Q36748207-D4450460-79B0-4C44-9315-A77384C5558FQ37020835-1F5597EB-56ED-4781-B7CE-C4DA0D4E0D09Q37107613-235499E0-5254-4A92-9B44-E3EDC5220243Q37819332-E4FBBD68-1BA3-4B74-887C-418CA944BC33Q38017594-C03B7832-87DD-42CD-B562-98ED7A4C27BFQ38515496-45E12525-AD8F-43C3-9D21-C69FE9F4EB4FQ38657057-B65C63B0-55DE-40CC-89F4-F5313B654450Q38720370-EC60D643-BF92-47C3-8C27-9723CEF5BD18Q38894951-7D73F686-E406-42AF-8AA3-ACFE37214948Q38915433-C21DE0B8-EB3F-446E-AD24-1045A9C41DB7Q39201583-9B101889-6EBD-40E8-9DA3-95BD122DBA80Q39298998-380E9A7D-BBA1-4B98-B6A3-FA2F6C529E08Q40204188-79EF0170-092D-45A7-AF57-265134FDD87DQ40239635-F6B48056-1659-401E-BB85-445FD3AC0722Q40305595-7621EB08-049E-4555-A198-E76FB6DF6592Q40484635-5B9FB003-1413-4892-B739-5C0D007E2F45Q42456210-B0C75C08-41B9-461C-87F0-28D06CDD7FBCQ44013589-25CF0F88-E350-46FA-A83E-317693E89F5CQ45316793-A0CA3EA1-9921-4A52-866E-7E74764AA11E
P2860
Activator protein 2alpha inhibits tumorigenicity and represses vascular endothelial growth factor transcription in prostate cancer cells.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Activator protein 2alpha inhib ...... tion in prostate cancer cells.
@en
type
label
Activator protein 2alpha inhib ...... tion in prostate cancer cells.
@en
prefLabel
Activator protein 2alpha inhib ...... tion in prostate cancer cells.
@en
P2093
P1433
P1476
Activator protein 2alpha inhib ...... tion in prostate cancer cells.
@en
P2093
Curtis Pettaway
Maribelis Ruiz
Menashe Bar-Eli
Oliver Stoeltzing
Renduo Song
P304
P356
10.1158/0008-5472.CAN-03-2751
P407
P577
2004-01-01T00:00:00Z